Patricia L. Allen
Ms. Patricia L. Allen, CPA, is a Chief Financial Officer at Vividion Therapeutics, Inc., an Independent Director at Yumanity Therapeutics, Inc. and an Independent Director at Deciphera Pharmaceuticals, Inc. She is on the Board of Directors at Yumanity Therapeutics, Inc., SwanBio Therapeutics, Inc., Anokion SA, Inversago Pharma, Inc., Deciphera Pharmaceuticals, Inc., Deciphera Pharmaceuticals LLC and Kanyos Bio, Inc. Ms. Allen was previously employed as a Chief Financial & Accounting Officer by Zafgen, Inc., a Treasurer & Vice President-Finance by Alnylam Pharmaceuticals, Inc., a Finance Director by Alkermes, Inc., and an Audit Manager by Deloitte & Touche LLP. She also served on the board at Yumanity, Inc. She received her undergraduate degree from Bryant University.
Transactions
| 06/05/2020 | 5,635 | Disposition at $55.9 per share. | 314,997 |
| 06/05/2020 | 5,635 | Derivative/Non-derivative trans. at $25.73 per share. | 144,988 |
| 06/03/2020 | 6,365 | Disposition at $59.14 per share. | 376,427 |
| 06/03/2020 | 6,365 | Derivative/Non-derivative trans. at $25.73 per share. | 163,771 |
| 01/24/2020 | 700 | Disposition at $67.36 per share. | 47,152 |
| 01/24/2020 | 6,496 | Disposition at $66.55 per share. | 432,309 |
| 01/24/2020 | 17,804 | Disposition at $65.93 per share. | 1,173,818 |
| 01/24/2020 | 25,000 | Derivative/Non-derivative trans. at $3.95 per share. | 98,750 |
